glutathione peroxidase 1 lung Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities The role of glutathione peroxidase-1
Description
Retrieved from DOI: 10.2337/dc07-1062 Diabetes with Disaster
Official guidance from the Food and Drug Administration and Pfizer-BioNTech state that the two doses should be administered 21 days apart based on the results of clinical trials
[DOI] [PubMed] [Google Scholar] 110.Wang Y., Liu Q., Zhao W., Zhou X., Miao G., Sun C., Zhang H
A Multicenter, Randomized, Open-Label, Active-Controlled Phase II Clinical Trial to Explore the Efficacy and Safety of Different Doses of TQC3927 Inhaled Powder in Patients With Chronic Obstructive Pulmonary Disease
Front Synaptic Neurosci
